Skip to main content

Advances in Therapy

Ausgabe 7/2022

Inhalt (26 Artikel)

Open Access Review

Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review

Cynthia Girman, Mary P. Panaccio, Kyle Hayes, John Niewoehner, George J. Wan

Original Research

The Impact of a Prenatal Education Program for Opioid-Dependent Mothers on Breastfeeding Rates of Infants at Risk for Neonatal Abstinence Syndrome

Brian Brocato, David Lewis, Fabien Eyal, Susan Baker, Casey Armistead, Alan David Kaye, Elyse M. Cornett, Richard M. Whitehurst Jr.

Original Research

Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea

Myung-Yong Lee, Sola Han, Oh Young Bang, Young Keun On, Sung-Won Jang, Seongwook Han, Jaeyun Ryu, Yoo-Jung Park, Seongsik Kang, Hae Sun Suh, Young-Hoon Kim

Open Access Original Research

Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study

Natalia Bello, Julie A. Birt, Jennifer Workman, Xian Zhou, Jorge A. Ross-Terres, Michelle Petri

Open Access Original Research

Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study

Markus Cornberg, Adriana Ahumada, Alessio Aghemo, Massimo Andreoni, Abhi Bhagat, Isabel Butrymowicz, Michal Carmiel, Gabriel Chodick, Brian Conway, Yanna Song, Antonio Gasbarrini, Dietrich Hüppe, Francisco Jorquera Plaza, Pietro Lampertico, Maria Luisa Manzano Alonso, Lindsay Myles, Marcello Persico, Alnoor Ramji, Christoph Sarrazin, Erica Villa, Clara Weil, Juan Isidro Uriz Otano

Open Access Original Research

Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations

Paul K. Paik, Boris M. Pfeiffer, Helene Vioix, Andrea Garcia, Maarten J. Postma

Original Research

The Cost-Effectiveness of Oral Semaglutide in Spain: A Long-Term Health Economic Analysis Based on the PIONEER Clinical Trials

Josep Franch-Nadal, Samuel J. P. Malkin, Barnaby Hunt, Virginia Martín, María Gallego Estébanez, Josep Vidal

Open Access Original Research

Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews

Mark Gudesblatt, Cortnee Roman, Barry A. Singer, Hollie Schmidt, Jessica Thomas, Sai L. Shankar, Jennifer Lyons, Shivani Kapadia

Open Access Original Research

Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases

Craig Leonardi, Baojin Zhu, William N. Malatestinic, William J. Eastman, Jiaying Guo, Mwangi J. Murage, Casey Kar-Chan Choong, Russel Burge, Andrew Blauvelt

Open Access Original Research

A Computational Platform Integrating a Mechanistic Model of Crohn’s Disease for Predicting Temporal Progression of Mucosal Damage and Healing

Sai Phanindra Venkatapurapu, Ryuichi Iwakiri, Eri Udagawa, Nikhil Patidar, Zhen Qi, Ryoko Takayama, Kei Kumar, Yuki Sato, Marcelo Behar, Patrick Offner, Gaurav Dwivedi, Haruna Miyasaka, Ryohsuke Ken Suzuki, Anna Lissa Hamada, Paul M. D’Alessandro, Jovelle Fernandez

Open Access Original Research

Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD

Angelo Maria Minnella, Chiara Centini, Gloria Gambini, Maria Cristina Savastano, Valeria Pagliei, Benedetto Falsini, Stanislao Rizzo, Gabriele Ciasca, Martina Maceroni

Open Access Original Research

Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada

Jean Grégoire, Salimah Champsi, Manon Jobin, Laura Martinez, Michael Urbich, Raina M. Rogoza

Original Research

A Decreased Absolute Number of Treg Cells in Patients with Active Rheumatoid Arthritis is Associated with Elevated Serum Osteopontin Levels with Disease Progression

Jian-Fang Xie, Jia Wang, Huan-Huan Bai, Jiao-Jiao He, Rui-Huan Jia, Xia Wang, Wen-Qi Zhang, Xiang-Cong Zhao, Xian-Cheng Zhang, Guang-Ying Liu, Xiao-Feng Li

Open Access Original Research

Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status

Qing Huang, Kathleen L. Deering, Qing Harshaw, Lori A. Leslie

Open Access Original Research

Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study

Antimo Moretti, Sara Liguori, Marco Paoletta, Francesca Gimigliano, Giovanni Iolascon

Original Research

XaMINA: A Real-World, Prospective, Observational Study of Treatment-Naïve Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation in Asia

Ping-Yen Liu, Eue-Keun Choi, Tae-Seok Kim, Jen-Yuan Kuo, Jung Myung Lee, Young Keun On, Sang-Weon Park, Hyung-Wook Park, Dong-Gu Shin, Lili Wang, Hsueh-Wei Yen, Moon-Hyoung Lee

Original Research

Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China

Haijing Guan, Chunping Wang, Zhigang Zhao, Sheng Han

Open Access Original Research

Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example

Eliza Kruger, Paul McNiven, Deborah Marsden

Open Access Original Research

Treatment Goals for Achondroplasia: A Qualitative Study with Parents and Adults

Sarah A. McGraw, Jeff C. Henne, James Nutter, Adelpha Abrahamson Larkin, Er Chen

Open Access Brief Report

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases

Francesco Bonella, Vincent Cottin, Claudia Valenzuela, Marlies Wijsenbeek, Florian Voss, Klaus B. Rohr, Susanne Stowasser, Toby M. Maher

Open Access Study Protocol

MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases

Wayne J. G. Hellstrom, Radboud J. E. M. Dolhain, Timothy E. Ritter, Timothy R. Watkins, Sarah J. Arterburn, Goele Dekkers, Angi Gillen, Caroline Tonussi, Leen Gilles, Alessandra Oortwijn, Katrien Van Beneden, Dick E. de Vries, Suresh C. Sikka, Dirk Vanderschueren, Walter Reinisch

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.